Similar articles

• Role of neurohormonal modulators in heart failure with relatively preserved systolic function.

  Rapp JA, Gheorghiade M. Rapp JA, et al. Heart Fail Clin. 2005 Apr;1(1):77-93. doi: 10.1016/j.hfc.2004.10.003. Epub 2005 Jan 7. Heart Fail Clin. 2005. PMID: 17386836 Review. No abstract available.
• Genomic variation and neurohormonal intervention in heart failure.

  McNamara DM. McNamara DM. Heart Fail Clin. 2010 Jan;6(1):35-43. doi: 10.1016/j.hfc.2009.08.004. Heart Fail Clin. 2010. PMID: 19945059 Free PMC article. Review.
• Pharmacogenetics in heart failure: promises and challenges.

  de Boer RA, van der Harst P, van Veldhuisen DJ, van den Berg MP. de Boer RA, et al. Expert Opin Pharmacother. 2009 Aug;10(11):1713-25. doi: 10.1517/14656560903025171. Expert Opin Pharmacother. 2009. PMID: 19558337 Review.
• The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.

  Porcu M. Porcu M. Ital Heart J. 2002 Jul;3(7):437-8. Ital Heart J. 2002. PMID: 12189976 No abstract available.
• Pharmacogenomics of heart failure.

  Lymperopoulos A, French F. Lymperopoulos A, et al. Methods Mol Biol. 2014;1175:245-57. doi: 10.1007/978-1-4939-0956-8_10. Methods Mol Biol. 2014. PMID: 25150872